Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo Controlled, Double-blind, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Naloxone HCl IV in Patients With Stroke

NCT05301712 is registered in ClinicalTrials.gov with Samjin Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05301712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05301712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo Controlled, Double-blind, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Naloxone HCl IV in Patients With Stroke
Lead sponsor
Samjin Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
August 7, 2018
Completion date
July 10, 2023
Enrollment
446 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute